期刊
ANTIVIRAL RESEARCH
卷 92, 期 2, 页码 125-138出版社
ELSEVIER
DOI: 10.1016/j.antiviral.2011.07.015
关键词
Viral hemorrhagic fever; Monkey models; Rhesus macaques; Arenaviruses; LCMV; Lassa fever virus
资金
- NIAID NIH HHS [R21 AI074790-01A2, R21 AI074790-02S1, R21 AI053619-02, R21 AI053619, R01 AI046244-03, R01 AI046244-04, R21 AI074790] Funding Source: Medline
- NIDCR NIH HHS [R21 DE015061, R21 DE015061-02] Funding Source: Medline
Arenaviruses such as Lassa fever virus (LASV) and lymphocytic choriomeningitis virus (LCMV) are benign in their natural reservoir hosts, and can occasionally cause severe viral hemorrhagic fever (VHF) in nonhuman primates and in human beings. LCMV is considerably more benign for human beings than Lassa virus, however certain strains, like the LCMV-WE strain, can cause severe disease when the virus is delivered as a high-dose inoculum. Here we describe a rhesus macaque model for Lassa fever that employs a virulent strain of LCMV. Since LASV must be studied within Biosafety Level-4 (BSL-4) facilities, the LCMV-infected macaque model has the advantage that it can be used at BSL-3. LCMV-induced disease is rarely as severe as other VHF, but it is similar in cases where vascular leakage leads to lethal systemic failure. The LCMV-infected macaque has been valuable for describing the course of disease with differing viral strains, doses and routes of infection. By monitoring system-wide changes in physiology and gene expression in a controlled experimental setting, it is possible to identify events that are pathognomonic for developing VHF and potential treatment targets. (C) 2011 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据